Jilin Shulan Synthetic Pharmaceutical Co. Ltd.

Warning LetterOpen

ChinaFEI 3003091092Issued May 14, 2018

View FDA's record for FEI 3003091092

Source: FDA warning letter records. FDA has not published the text of this letter. To check it, open FDA's record for this establishment, listed under FEI 3003091092.

Violations0

Issue DateMay 14, 2018

Product TypeOther

StatusOpen

Letter Details

Firm: Jilin Shulan Synthetic Pharmaceutical Co. Ltd.
Location: China
FEI Number: 3003091092
Country: China
Issue Date: May 14, 2018
Issuing Office: N/A
Product Type: Other
Status: Open

Summary

Based on limited metadata, the FDA issued a Warning Letter to Jilin Shulan Synthetic Pharmaceutical Co. Ltd., a pharmaceutical manufacturer, on May 14, 2018. Without access to the full letter text or specific subject line, the exact nature of the violations cannot be determined from the available information. The letter pertains to products categorized as "Other" and was issued through an unspecified FDA office, limiting clarity on the specific regulatory scope and product category involved.

Jilin Shulan Synthetic Pharmaceutical Co. Ltd. FDA Warning Letter, May 14, 2018